Preview Mode Links will not work in preview mode

Dec 8, 2018

In this special edition of the MDedge Daily News, MDedge Hematology Editor, Mary Ellen Schneider, and Nick Andrews present some of the most important news with full comments from researchers and clinicians. 

  1. CLL resistance mechanism to venetoclax identified.
  2. Rivaroxaban may reduce VTE risk in...